1. Home
  2. KELYB vs STRO Comparison

KELYB vs STRO Comparison

Compare KELYB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc. Class B

KELYB

Kelly Services Inc. Class B

N/A

Current Price

$18.00

Market Cap

551.2M

ML Signal

N/A

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$30.94

Market Cap

491.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KELYB
STRO
Founded
1946
2003
Country
United States
United States
Employees
4900
133
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
491.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KELYB
STRO
Price
$18.00
$30.94
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$31.33
AVG Volume (30 Days)
2.6K
252.3K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.72
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.38
$0.67
52 Week High
$125.00
$43.85

Technical Indicators

Market Signals
Indicator
KELYB
STRO
Relative Strength Index (RSI) 50.27 51.94
Support Level $11.66 $23.53
Resistance Level $18.11 $30.94
Average True Range (ATR) 0.86 2.69
MACD -0.18 0.51
Stochastic Oscillator 43.37 70.12

Price Performance

Historical Comparison
KELYB
STRO

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: